Her primary areas of study are Virology, Simian immunodeficiency virus, Virus, Immunology and Viremia. Virology is a component of her Viral replication, Viral Vaccine and Viral load studies. Her research in Viral replication intersects with topics in Acquired immunodeficiency syndrome, Spleen, Lymphatic system, Clone and Disease.
The concepts of her Virus study are interwoven with issues in Peripheral blood mononuclear cell, Antibody and Immune system. Her Immunology research integrates issues from Vaccinia, HIV vaccine and Toxicity. Her Viremia research incorporates elements of Simian AIDS and Immunization.
The scientist’s investigation covers issues in Virology, Simian immunodeficiency virus, Virus, Immunology and Viremia. Her studies in Virology integrate themes in fields like Antibody and Immunodeficiency. Her work in Simian immunodeficiency virus addresses issues such as Viral disease, which are connected to fields such as Lymphatic system.
Her work in Virus addresses subjects such as Acquired immunodeficiency syndrome, which are connected to disciplines such as Simian. Her research investigates the connection between Immunology and topics such as Vaccinia that intersect with issues in HIV vaccine. In her study, Toxicity is inextricably linked to Regimen, which falls within the broad field of Viremia.
Marta L. Marthas focuses on Immunology, Virology, Simian immunodeficiency virus, Virus and Viremia. Her Immunology study which covers Regimen that intersects with Reverse-transcriptase inhibitor, Toxicity and Gestation. Her Virology research is multidisciplinary, incorporating elements of T cell, Immune system, HIV vaccine, Cytotoxic T cell and Modified vaccinia Ankara.
The study incorporates disciplines such as Vagina, Secretion and Viral disease in addition to Immune system. Her studies deal with areas such as Vaccinia, CD8 and Lentivirus as well as Simian immunodeficiency virus. Her work in Virus covers topics such as Transmission which are related to areas like Simian and Simian AIDS.
Her primary scientific interests are in Immunology, Virology, Simian immunodeficiency virus, Virus and Immune system. The Viremia and Effector research she does as part of her general Immunology study is frequently linked to other disciplines of science, such as Breast feeding and Proinflammatory cytokine, therefore creating a link between diverse domains of science. Her Viremia study incorporates themes from Titer, Distribution, Antibody-dependent cell-mediated cytotoxicity and Physiology.
Marta L. Marthas combines subjects such as Monoclonal, Immunoglobulin G, Cell-mediated cytotoxicity, Antibody and Monoclonal antibody with her study of Effector. Her Virology research incorporates themes from Infectious disease and AIDS Vaccines. Her biological study spans a wide range of topics, including Pregnancy, Gestation, Pharmacokinetics, Regimen and Reverse-transcriptase inhibitor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus
Harry Kestler;Toshiaki Kodama;Douglas Ringler;Marta Marthas.
Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection.
Koen K. A. Van Rompay;Christopher J. Berardi;Nancy L. Aguirre;Norbert Bischofberger.
Passive Immunization of Newborn Rhesus Macaques Prevents Oral Simian Immunodeficiency Virus Infection
Koen K. A. Van Rompay;Christopher J. Berardi;Stephan Dillard-Telm;Ross P. Tarara.
The Journal of Infectious Diseases (1998)
Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia.
Chris J Miller;Marta Marthas;Judith Torten;Nancy J. Alexander.
Journal of Virology (1994)
Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus.
Andrew A. Lackner;Peter Vogel;Peter Vogel;Ross A. Ramos;Ross A. Ramos;J. D. Kluge.
American Journal of Pathology (1994)
Two Low Doses of Tenofovir Protect Newborn Macaques against Oral Simian Immunodeficiency Virus Infection
Koen K. A. Van Rompay;Michael B. McChesney;Nancy L. Aguirre;Kimberli A. Schmidt.
The Journal of Infectious Diseases (2001)
Biological Effects of Short-Term or Prolonged Administration of 9-[2-(Phosphonomethoxy)Propyl]Adenine (Tenofovir) to Newborn and Infant Rhesus Macaques
Koen K. A. Van Rompay;Laurie L. Brignolo;Dennis J. Meyer;Christopher Jerome.
Antimicrobial Agents and Chemotherapy (2004)
Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV.
Marta Marthas;S. Sutjipto;J. Higgins;B. Lohman.
Journal of Virology (1990)
9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques.
K. K. A. Van Rompay;J. M. Cherrington;M. L. Marthas;C. J. Berardi.
Antimicrobial Agents and Chemotherapy (1996)
A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge.
B. L. Lohman;M. B. McChesney;C. J. Miller;E. McGowan.
Journal of Virology (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: